/lifesciences?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Life Sciences Copyright 2025 sa¹ú¼Ê´«Ã½. en-US Wed, 24 Dec 2025 06:38:19 +0000 /lifesciences/articles/2425482?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2425482 French pharmaceutical giant Sanofi SA said Wednesday that it will buy Dynavax Technologies, a U.S. vaccine developer, for $2.2 billion in a recommended cash deal to expand its adult immunization products. Tue, 23 Dec 2025 21:15:07 +0000 /lifesciences/articles/2423235?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2423235 State and federal courts have handed down rulings in Illinois cases this year that made clear plaintiffs must allege concrete injury for common law standing, narrowed the scope of the federal anti-kickback statute and laid out a new standard for certifying collective actions. Tue, 23 Dec 2025 20:31:28 +0000 /lifesciences/articles/2424701?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424701 The Federal Circuit is set to hear several intellectual property cases in January, including one over a nine-figure patent judgment against cybersecurity company Gen Digital tied to a contempt finding against a major law firm that represented it, and another over the tech industry's long-running crusade against patent review denials based on related litigation. Tue, 23 Dec 2025 20:20:12 +0000 /lifesciences/articles/2425381?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2425381 Philadelphia on Tuesday sued drug manufacturers Eli Lilly, Novo Nordisk and Sanofi, along with several pharmacy benefit managers, joining multidistrict litigation in New Jersey federal court accusing the companies of illegally inflating the price of insulin. Tue, 23 Dec 2025 19:56:49 +0000 /lifesciences/articles/2425317?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2425317 Amarin Pharma Inc. on Tuesday urged the U.S. Supreme Court to reject the U.S. solicitor general's call to hear a patent case involving generic drug "skinny labels," saying the dispute over the company's heart drug Vascepa deals with factual issues not suitable for high court review. Tue, 23 Dec 2025 19:52:24 +0000 /lifesciences/articles/2424985?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424985 Medical device provider AdaptHealth Corp. has agreed to pay $35 million to settle a lawsuit accusing it of deceiving shareholders about its revenue projections as it "routinely engaged in improper and unethical tactics to inflate sales numbers."  Tue, 23 Dec 2025 19:35:36 +0000 /lifesciences/articles/2425177?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2425177 A group of Democratic U.S. senators has asked Commerce Secretary Howard Lutnick not to move forward with a proposed overhaul of the U.S. patent fee system that reportedly would implement fees based on a patent's value, saying such changes would create a "prohibitive bar to innovation for start-ups and other small-to-mid-size businesses." Tue, 23 Dec 2025 19:26:22 +0000 /lifesciences/articles/2425220?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2425220 U.S. Patent and Trademark Office Director John Squires has paused the Patent Trial and Appeal Board's review of a Hydrafacial LLC skin treatment patent to consider the effect of a related U.S. International Trade Commission decision. Tue, 23 Dec 2025 16:52:18 +0000 /lifesciences/articles/2425141?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2425141 The U.S. government urged the Ninth Circuit to stay a court order barring agencies from laying off workers through next month under the shutdown deal, saying the court intruded on federal labor panels' territory and the funding resolution didn't bar layoffs agencies had in the works. Tue, 23 Dec 2025 16:42:30 +0000 /lifesciences/articles/2425157?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2425157 Advice that McDonald Hopkins LLC gave a Florida hospital manager about potential exposure to criminal prosecution for healthcare fraud is neither privileged nor work product, and so should be handed over to a Blue Cross health insurer being sued for malicious prosecution in Georgia federal court, the insurer said. Tue, 23 Dec 2025 16:27:28 +0000 /lifesciences/articles/2418969?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2418969 New Jersey courts saw some history-making litigation come to a close over the course of 2025, including the largest environmental settlement ever achieved by a single state and the first clergy abuse trial verdict since the statute of limitations on child sexual abuse claims was extended. Another notable development was the state's federal bench exercising a rarely used authority to reject President Donald Trump's pick for interim U.S. attorney. Tue, 23 Dec 2025 15:55:27 +0000 /lifesciences/articles/2425102?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2425102 Drug manufacturers Regeneron Pharmaceuticals and Sanofi were hit with a lawsuit Monday from a Georgia woman alleging the companies have covered up a "strong and consistent causal relationship" between their drug Dupixent and a form of non-Hodgkins lymphoma. Tue, 23 Dec 2025 15:15:49 +0000 /lifesciences/articles/2424896?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424896 Baker Botts LLP has hired two new partners in its intellectual property and environmental safety and incident response groups, who will both be based in the firm's Washington, D.C., office, Baker Botts said in recent announcements. Tue, 23 Dec 2025 14:44:07 +0000 /lifesciences/articles/2424660?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424660 The estate of a woman who died of a tianeptine overdose is suing the makers and sellers of tianeptine products in Pennsylvania state court, saying while they market the products as safe diet supplements, they're actually highly addictive opioids. Tue, 23 Dec 2025 13:14:03 +0000 /lifesciences/articles/2424997?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424997 A Baltimore jury late Monday returned a walloping verdict of more than $1.5 billion in favor of a woman who claimed that Johnson & Johnson talc products caused her mesothelioma, which her attorneys say is the largest verdict against the company for a single plaintiff. Mon, 22 Dec 2025 22:18:38 +0000 /lifesciences/articles/2424767?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424767 Tela Bio Inc. slapped Becton Dickinson and Co. and its subsidiaries with an antitrust lawsuit Friday in Pennsylvania federal court accusing the medical tech giant of abusing its dominant position in the hernia mesh market to block Tela's product and keep Becton's "costlier and clinically inferior" mesh on hospital shelves in the U.S. Mon, 22 Dec 2025 20:21:30 +0000 /lifesciences/articles/2419621?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2419621 The Federal Circuit and U.S. Court of Federal Claims ruled on several consequential issues impacting government contractors this year, including deciding who constitutes an "interested party" capable of lodging a bid protest and invalidating a settlement between the Pentagon and one of its major contractors. Here, Law360 reviews the top government contracts-related rulings in 2025. Mon, 22 Dec 2025 20:00:52 +0000 /lifesciences/articles/2424824?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424824 Apple has urged a California federal judge to grant its combined motion for judgment or a new trial for its $634 million trial loss over a Masimo patient monitor patent, arguing that no reasonable jury could have reached the verdict and that the tech giant was "severely prejudiced" by erroneous court rulings. Mon, 22 Dec 2025 18:07:49 +0000 /lifesciences/articles/2424679?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424679 The Sixth Circuit vacated a nearly $7 million restitution order against a pharmaceutical salesman convicted of healthcare fraud, finding an Ohio federal court erred in calculating that amount and apportioning liability. Mon, 22 Dec 2025 17:12:14 +0000 /lifesciences/articles/2424713?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2424713 MSN Pharmaceuticals has pushed back against Novartis' efforts to save its case accusing the generic-drug maker of infringing a patent covering the blockbuster cardiovascular drug Entresto, telling the Federal Circuit that the appeal "reveals no district court error, just Novartis' poor litigation strategy."